ACNE VULGARIS: A REVIEW ON PATHOPHYSIOLOGY AND TREATMENT

Authors

  • Shyam Baboo Prasad Lovely Professional University

Abstract

ABSTRACT
Acne vulgaris is a disease associated with sebaceous follicle. It starts appearing after the onset of puberty and can extend up to 40-50 years of age. As
far as the pathogenesis of acne is concerned, it is not fully understood up till now. Treatment of acne is very frustrating and involves an understanding
of etiopathological factors. This review focuses on various factors accountable, pathogenesis, and therapy of acne.
Keywords: Acne, Skin diseases, Acne therapy, Propionibacterium acnes, Acne vulgaris.

Downloads

Download data is not yet available.

Author Biography

Shyam Baboo Prasad, Lovely Professional University

Assistant Professor, Department of Pharmacognosy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India-144411

References

REFERENCES

Kaur D, Prasad SB. Anti acne activity of acetone extract of Plumbago

indica root. Asian J Pharm Clin Res 2016;9(2):285-7.

Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology

patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J

Dermatol 1998;139(5):846-50.

Cunliffe WJ. Natural history of acne. In: Cunliffe WJ, editor. Acne.

London: Martin Dunitz; 1989. p. 2-10.

Gollnick HP, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A.

Pathogenesis and pathogenesis related treatment of acne. J Dermatol

;18(9):489-99.

Harris HH, Downing DT, Stewart ME, Strauss JS. Sustainable rates of

sebum secretion in acne patients and matched normal control subjects.

J Am Acad Dermatol 1983;8(2):200-3.

Blauer M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P.

Location of androgen receptor in human skin. J Invest Dermatol

;97(2):264-8.

Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO,

Boersma WJ. Localization of androgen receptors in human skin by

immunohistochemistry: Implications for the hormonal regulation

of hair growth, sebaceous glands and sweat glands. J Endocrinol

;133(3):467-75.

Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD,

Russell DW. Tissue distribution and ontogeny of steroid 5a-reductase

isozyme expression. J Clin Invest 1993;92(2):903-10.

Luu-The V, Sugimoto Y, Puy L, Labrie Y, Lopez-Solache I, Singh M,

et al. Characterization, expression, and immunohistochemical

localization of 5-a-reductase in human skin. J Invest Dermatol

;102(2):221-6.

Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S.

Activity of the type I 5 a-reductase exhibits regional differences

in isolated sebaceous glands and whole skin. J Invest Dermatol

;105(2):209-14.

Chen W, Zouboulis CC, Orfanos CE. The 5 areductase system and its

inhibitors: Recent development and its perspective in treating androgendependent

skin disorders. Dermatology 1996;193(3):177-84.

Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M,

et al. Corticotropin-releasing hormone: An autocrine hormone that

promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A

;99(10):7148-53.

Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW,

Kronenberg HM, Larsen PR, editors. Williams Textbook of

Endocrinology. Philadelphia, PA: WB. Saunders; 1998. p. 517-664.

Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M,

Hornemann S, et al. The human sebocyte culture model provides new

insights into development and management of seborrhoea and acne.

Dermatology 1998;196(1):21-31.

Leyden J, Bergfeld W, Drake L, Dunlap F, Goldman MP, Gottlieb AB,

et al. A systemic type I 5 alpha-reductase inhibitor is ineffective in the

treatment of acne vulgaris. J Am Acad Dermatol 2004;50(3):443-7.

Placzek M, Arnold B, Schmidt H, Gaube S, Keller E, Plewig G, et al.

Elevated 17-hydroxyprogesterone serum values in male patients with

acne. J Am Acad Dermatol 2005;53(6):955-8.

Zouboulis CC, Böhm M. Neuroendocrine regulation of sebocytes - A

pathogenetic link between stress and acne. Exp Dermatol

;13 Suppl 4:31-5.

Weeks JG, McCarty L, Black T, Fulton JE Jr. The inability of a

bacterial lipase inhibitor to control acne vulgaris. J Invest Dermatol

;69(2):236-43.

Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids

and acne. J Am Acad Dermatol 1986;14:221-5.

Zouboulis C. Update on sebaceous gland physiology: Induction of

inflammation and its clinical implications. JEADV 2001;15 Suppl 2:102.

Guy R, Kealey T. Modelling the infundibulum in acne. Dermatology

;196(1):32-7.

Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Proinflammatory

levels

of interleukin-1 alpha-like

bioactivity

are

present

in

the

majority

of

open

comedones

in

acne

vulgaris.

J

Invest

Dermatol

;98(6):895-901.

Eller MS, Yaar M, Ostrom K, Harkness DD, Gilchrest BA. A role for

interleukin-1 in epidermal differentiation: Regulation by expression of

functional versus decoy receptors. J Cell Sci 1995;108:2741-6.

Akamatsu H, Horio T. The possible role of reactive oxygen species

generated by neutrophils in mediating acne inflammation. Dermatology

;196(1):82-5.

Marples RR, McGinley KJ. Corynebacterium acnes and other anaerobic

diphtheroids from human skin. J Med Microbiol 1974;7(3):349-57.

Holland KT. Microbiology of acne. In: Cunliffe WJ, editor. Acne.

London: Martin Dunitz; 1989. p. 178-210.

Leyden JJ, McGinley KJ, Mills OH, Kligman AM. Age-related changes

in the resident bacterial flora of the human face. J Invest Dermatol

;65(4):379-81.

McGinley KJ, Webster GF, Ruggieri MR, Leyden JJ. Regional

variations in density of cutaneous propionibacteria: Correlation of

Propionibacterium acnes populations with sebaceous secretion. J Clin

Microbiol 1980;12(5):672-5.

Eady EA, Ingham E. Propionibacterium acnes – Friend or foe. Rev Med

Microbiol 1994;5(3):163-73.

Webster GF, Leyden JJ, Musson RA, Douglas SD. Susceptibility

of Propionibacterium acnes to killing and degradation by human

neutrophils and monocytes in vitro. Infect Immun 1985;49(1):116-21.

Kirschbaum JO, Kligman AM. The pathogenic role of Corynebacterium

acnes in acne vulgaris. Arch Dermatol 1963;88:832-3.

Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant

propionibacteria in antibiotic treated acne patients: Association with

therapeutic failure. Br J Dermatol 1989;121(1):51-7.

Holland KT, Holland DB, Cunliffe WJ, Cutcliffe AG. Detection of

Propionibacterium acnes polypeptides which have stimulated an

immune response in acne patients but not in normal individuals. Exp

Dermatol 1993;2(1):12-6.

Layton AM, Morris C, Cunliffe WJ, Ingham E. Immunohistochemical

investigation of evolving inflammation in lesions of acne vulgaris. Exp

Dermatol 1998;7(4):191-7.

Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology

;206(1):24-8.

Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ.

Inflammatory events are involved in acne lesion initiation. J Invest

Dermatol 2003;121(1):20-7.

Zouboulis CC, Nestoris S, Adler YD, Orth M, Orfanos CE, Picardo M,

et al. A new concept for acne therapy: A pilot study with zileuton, an

oral 5-lipoxygenase inhibitor. Arch Dermatol 2003;139(5):668-70.

Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM.

The psychosocial effects of acne on adolescents. Pediatr Dermatol

;8(4):332-8.

Degitz K, Placzek M, Arnold B, Plewig G. Endokrinologische Aspekte

bei Akne. In: Plewig G, Degitz K, editors. (Hrsg): Fortschritte Der

Praktischen Dermatologie Und Venerologie. Vol. 17. Berlin: Springer;

p. 172-9.

Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986;115(3):386.

Simpson NB. Social and economic aspects of acne and the cost-

effectiveness of isotretinoin. J Dermatol Treat 1993;4 Suppl 2:S6-9.

Burke BM, Cunliffe WJ. The assessment of acne vulgaris--the Leeds

technique. Br J Dermatol 1984;111(1):83-92.

Harkaway KS, McGinley KJ, Foglia AN, Lee WL, Fried F, Shalita AR,

et al. Antibiotic resistance patterns in coagulase-negative staphylococci

after treatment with topical erythromycin, benzoyl peroxide, and

combination therapy. Br J Dermatol 1992;126(6):586-90.

Cunliffe WJ, Holland KT. Clinical and laboratory studies on treatment

with 20% azelaic acid cream for acne. Acta Derm Venereol Suppl

(Stockh) 1989;143:31-4.

Lipson AH, Collins F, Webster WS. Multiple congenital defects

associated with maternal use of topical tretinoin. Lancet

;341(8856):1352-3.

Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital

disorders. Lancet 1993;341(8854):1181-2.

Eady EA, Cove JH, Joanes DN, Cunliffe WJ. Topical antibiotics for

Asian J Pharm Clin Res, Vol 9, Issue 4, 2016, 54-59

Prasad

the treatment of acne vulgaris: A critical evaluation of the literature

on their clinical benefit and comparative efficacy. J Dermatol Treat

;1:215-26.

Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM.

Antibiotic resistant propionibacteria in acne: Need for policies to

modify antibiotic usage. BMJ 1993;306(6877):555-6.

Darley CR, Moore JW, Besser GM, Munro DD, Edwards CRW,

Rees LH, et al. Androgen status in women with late onset or persistent

acne vulgaris. Clin Exp Dermatol 1984;9:28-35.

Greenwood R, Brummitt L, Burke B, Cunliffe WJ. Acne: Double

blind clinical and laboratory trial of tetracycline, oestrogencyproterone

acetate,

and

combined treatment.

Br

Med J (Clin Res Ed)

;291(6504):1231-5.

Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F. Use

of cyproterone acetate (CPA) in the treatment of acne, hirsutism, and

virilism. J Steroid Biochem 1975;6(6):827-36.

Bottomley WW, Yip J, Knaggs H, Cunliffe WJ. Treatment of closed

comedones--comparisons of fulguration with topical tretinoin and

electrocautery with fulguration. Dermatology 1993;186(4):253-7.

Vahlquist A, Rollman O, Holland DB, Cunliffe WJ. Isotretinoin

treatment of severe acne affects the endogenous concentration of

vitamin A in sebaceous glands. J Invest Dermatol 1990;94(4):496-8.

Rademaker M, Wallace M, Cunliffe W, Simpson NB. Isotretinoin

treatment alters steroid metabolism in women with acne. Br J Dermatol

;124(4):361-4.

Perkins W, Crocket KV, Hodgins MB, Mackie RM, Lackie JM. The

effect of treatment with 13-cis-retinoic acid on the metabolic burst of

peripheral blood neutrophils from patients with acne. Br J Dermatol

;124(5):429-32.

Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in

acne. J Am Acad Dermatol 1992;27:S2-7.

Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne

vulgaris--10 years later: A safe and successful treatment. Br J Dermatol

;129(3):292-6.

Cunliffe WJ, Gray JA, Macdonald-Hull S, Hughes BR, Calvert RT,

Burnside CJ, et al. Cost effectiveness of isotretinoin. J Dermatol Treat

;1:285-8.

Walker BR, MacKie RM. Serum lipid elevation during isotretinoin

therapy for acne in the west of Scotland. Br J Dernsatol

;122(4):531-7.

Published

01-07-2016

How to Cite

Prasad, S. B. “ACNE VULGARIS: A REVIEW ON PATHOPHYSIOLOGY AND TREATMENT”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 4, July 2016, pp. 54-59, https://innovareacademics.in/journals/index.php/ajpcr/article/view/12866.

Issue

Section

Review Article(s)